📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Paternal Antigens, Maternal Killer Lymphocytes, and Reproduction

Lead Research Organisation: Babraham Institute
Department Name: UNLISTED

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Technical Summary

During pregnancy, the developing foetus expresses paternal surface antigens, yet it is normally not recognized by the mother as a foreign tissue graft and is not rejected. Instead the maternal immune system is 'reprogrammed' during pregnancy and is tolerant towards the foetus. This project investigates how maternal immune cells and foetal cells of the placenta interact on the molecular level to achieve a mutually beneficial partnership between mother and foetus that is essential for the success of pregnancy.

Planned Impact

unavailable

Publications

10 25 50
 
Description Pregnancy is a biological paradox, as the developing fetes carries half its genes from the father and should therefore be recognised by the mother as "foreign", similar to a tissue transplant. However, the foeto-maternal interface has developed unique strategies that prevent rejection of foetal-derived placental cells, i.e. those cells that are in direct contact with maternal tissue and blood and carry the father's surface antigens. In this study we have characterised the unique repertoire of paternal antigens expression on placental cells, and show that it is very unusual and different from other somatic cells. This will help the placental cells escape immune recognition. At the same time we demonstrate, however, that a low-level of maternal immune cell activation is essential for a normal, successful pregnancy. It is thus all about getting the balance right.
The impact of this work is very high for the clinic; it underpins why specific combinations of immune cell receptors and placental surface antigens are incompatible and don't allow a pregnancy, or lead to severe pregnancy complications such as pre-eclampsia in a proportion of couples.
Increased research capacity due to in-depth training of postdoctoral scientist. This work led to her appointment as an Associate Professor at the University of Poznan, Poland.
Exploitation Route This work is carried forward by our collaborators at the university of Cambridge who are investigating pregnancy disorders in humans for such detrimental antigen-receptor mismatches.
Sectors Healthcare

 
Description Investigating women with a history of recurrent miscarriage or other pregnancy complications for their specific immune cell receptor repertoire, in conjunction with that of the father.
Sector Healthcare
Impact Types Societal

 
Description School visit 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? Yes
Geographic Reach Local
Primary Audience Schools
Results and Impact presented basic research topic (intrauterine development and essential function of placenta) to primary school children

awareness and excitement of young people for science
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010
 
Description School's Day 
Form Of Engagement Activity Participation in an open day or visit at my research institution
Part Of Official Scheme? Yes
Geographic Reach Local
Primary Audience Schools
Results and Impact provided basic explanation of early development and the importance of the placenta for growth of a baby; hands-on experience for students in staining and microscopic analysis of a mouse placenta

rose awareness of research activities and importance of basic research to understand common pregnancy-associated diseases
Year(s) Of Engagement Activity 2006,2007,2008,2009,2010,2011,2012,2013,2014,2015,2016